DisseminatedScedosporium prolificansinfection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DisseminatedScedosporium prolificansinfection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics
Authors
Keywords
-
Journal
MYCOSES
Volume 57, Issue 9, Pages 572-576
Publisher
Wiley
Online
2014-04-25
DOI
10.1111/myc.12199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia
- (2013) Roberto Reinoso et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens
- (2013) C. Biswas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Use of FDG-PET/CT in Patients With Febrile Neutropenia
- (2013) Fidel J. Vos et al. SEMINARS IN NUCLEAR MEDICINE
- Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections
- (2012) Natalie K. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis
- (2012) Yukihiro Hamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
- (2011) H R Ashbee et al. BONE MARROW TRANSPLANTATION
- Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections
- (2010) A. Hot et al. CLINICAL MICROBIOLOGY AND INFECTION
- Accelerated Metabolism of Voriconazole and Its Partial Reversal by Cimetidine
- (2009) B. Moriyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Scedosporium prolificansOsteomyelitis in an Immunocompetent Child Treated with a Novel Agent, Hexadecylphospocholine (Miltefosine), in Combination with Terbinafine and Voriconazole: A Case Report
- (2009) Alison M. Kesson et al. CLINICAL INFECTIOUS DISEASES
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections
- (2008) Georgios Chamilos et al. MEDICAL MYCOLOGY
- Epidemiology and outcome ofScedosporium prolificansinfection, a review of 162 cases
- (2008) Juan Luis Rodriguez-Tudela et al. MEDICAL MYCOLOGY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started